In Vivo Star Anti-Mouse CD357 (GITR) Antibody

Cat # Size Price Quantity
5086011 mg$160
5086025 mg$400
50860325 mg$1100

Product Details


CloneDTA-1-m2a
ApplicationELISA, WB, Flow cytometry, IHC, ICC, animal model study
Host SpeciesCHO cells
ReactivityMouse
FormatLiquid
Target NameTNFRSF18, AITR, GITR, CD357
Product DescriptionIn Vivo Grade Recombinant Anti-mouse GITR Monoclonal Antibody
IsotypeMouse IgG2a Lambda
Antibody TypeRecombinant
Regulatory StatusRUO
Purity>95% by reducing SDS-PAGE
Endotoxin< 1 EU per 1 mg of the protein by the LAL method.
Storage Conditions4ºC
GradeIn vivo
Recommended UsageThis product is suitable for in vivo animal use. Optimal amounts need to be determined empirically for each experiment.
RRIDAB_3739360
Research AreasCo-stimulation, Tregs, Activated T cells, Cancer Immunology, Immune Checkpoints
See All FormatsClone DTA-1-m2a

Background Information


Glucocorticoid-induced tumor necrosis factor receptor–related protein (GITR), also known as CD357 or TNFRSF18, is a co-stimulatory receptor that plays an important role in regulating T cell activation, survival, and immune balance. GITR is constitutively expressed at high levels on regulatory T cells (Tregs) and at lower levels on naïve conventional T cells, with expression rapidly upregulated following T cell activation. It is also expressed on natural killer (NK) cells and some myeloid populations. Through its signaling, GITR influences both effector and regulatory arms of the immune system.

Structurally, GITR is a type I transmembrane glycoprotein and a member of the tumor necrosis factor receptor (TNFR) superfamily. Its extracellular region contains cysteine-rich domains typical of TNFR family members that mediate ligand binding. GITR has a single transmembrane segment and a cytoplasmic tail that lacks intrinsic enzymatic activity but recruits TNF receptor–associated factors (TRAFs), particularly TRAF2 and TRAF5. These adaptor proteins initiate downstream signaling cascades, including activation of NF-κB and MAPK pathways, which promote cell survival, proliferation, and cytokine production.

The primary ligand for GITR is GITR ligand (GITRL), also known as TNFSF18, which is expressed on activated antigen-presenting cells such as dendritic cells, macrophages, and B cells, as well as on endothelial cells in inflamed tissues. Engagement of GITR by GITRL provides a co-stimulatory signal that enhances effector T cell activation and resistance to suppression. In regulatory T cells, GITR signaling can transiently reduce suppressive function, thereby shifting the immune balance toward activation in certain contexts.

GITR has been implicated in a variety of disease settings. In autoimmune and inflammatory diseases, heightened GITR signaling may contribute to excessive T cell activation and tissue damage by weakening regulatory control. In allergic disease, GITR can promote Th2 responses and inflammation. In cancer, GITR is highly expressed on tumor-infiltrating Tregs, where it contributes to immune suppression within the tumor microenvironment. At the same time, GITR expression on effector T cells provides an opportunity to enhance anti-tumor immunity.

Therapeutically, GITR is an active target in immuno-oncology. Agonistic antibodies targeting GITR aim to simultaneously stimulate effector T cells and attenuate Treg-mediated suppression within tumors, thereby enhancing anti-tumor immune responses. These agents are being evaluated alone and in combination with immune checkpoint inhibitors. Conversely, strategies to inhibit GITR–GITRL interactions are being explored for the treatment of autoimmune and inflammatory diseases, highlighting GITR’s dual relevance as both a driver of immunity and a contributor to immune-mediated pathology.

Data Sheets


In Vivo Star Anti-Mouse CD357 (GITR) Antibody TDS

Related Protocols


Direct ELISA Protocol

Western Blot Protocol

Flow Cytometry Protocol

Related Products


Human GITRL/TNFSF18 Protein (N-His)

Human GITRL/TNFSF18 Protein (N-His-Avi)

Biotin Human GITRL/TNFSF18 Protein (N-His-Avi)

Human GITR (TNFRSF18) Protein (C-His-Avi)

Biotin Human GITR (TNFRSF18) Protein (C-His-Avi)

Human GITR (TNFRSF18) Protein (C-His)

PE Human GITR (TNFRSF18) Protein (C-His)

APC Human GITR (TNFRSF18) Protein (C-His)

Human GITR (TNFRSF18) Protein (C-Fc-Avi)

Frequently Asked Questions


What are In Vivo Star Biofunctional Antibodies?
In Vivo Star antibodies are premium-grade monoclonal antibodies purified and formulated specifically for use in animal studies. Each lot is manufactured under stringent quality controls to ensure the low endotoxin levels, high purity, and functional activity required for reliable in vivo results.

How are these antibodies different from standard research antibodies (e.g., for Western blot or flow cytometry)?
Standard research antibodies are optimized for in vitro detection assays and may contain preservatives, carrier proteins (like BSA), or higher endotoxin levels unsuitable for injection. In Vivo Star antibodies are formulated in injectable-grade, azide-free, low-endotoxin buffers and validated for functional bioactivity in living systems rather than just antigen binding.

What endotoxin and purity specifications do these antibodies meet?
All In Vivo Star antibodies are tested and certified to meet low-endotoxin thresholds (typically <1 EU/mg, lot-dependent) using the LAL (Limulus Amebocyte Lysate) assay, and are purified to ≥95% purity by SEC-HPLC or SDS-PAGE. Exact specifications are provided on the Certificate of Analysis (CoA) for each lot.

Are these antibodies azide-free and carrier-free?
All In Vivo Star antibodies are formulated without sodium azide and without carrier proteins such as BSA or gelatin, since both can interfere with animal physiology or immune readouts during in vivo studies.

Do you provide isotype controls?
Matched isotype control antibodies (same host species, isotype, and formulation) are available upon request for most clones to support proper experimental controls.

How should In Vivo Star antibodies be stored and handled?
Store at 4°C for short-term use and avoid repeated freeze-thaw cycles, which can reduce bioactivity; aliquoting is recommended for long-term storage per the product-specific storage instructions on the Certificate of Analysis. Always confirm storage conditions and expiration on the CoA that accompanies each lot, as these can vary slightly by antibody.

Have a product or application question? Consult our FAQs or contact us.